Skip to content
  • Home
  • Catalog
  • About/Leadership
  • Press
  • Contact
  • —
  • Sign in

Twitter
Instagram
TikTok
Linkedin
Youtube
Tumblr

Your cart

  • Home
  • Catalog
  • About/Leadership
  • Press
  • Contact
FUNanc1al
0

Insider Purchases: Inside the Buy

Tag: Alphatec

Robotic spine surgery technology beside a rising ATEC stock chart, illustrating Alphatec’s insider buying and free-cash-flow turnaround.

September 11, 2026

🩺 Alphatec (ATEC): CEO’s $1M Buy, Positive Free Cash Flow & an 11% Short-Squeeze Fuse 🦾🦴

Alphatec CEO Pat Miles just put $1.01 million of his own money into ATEC at $8.81. With positive free cash flow, improving EBITDA, Valence robotics and 11% short interest, is this battered spine-medtech stock finally reaching its turnaround moment?

 

Read entire article

Tags: Alphatec, Alphatec Holdings, Alphatec stock, ATEC, ATEC stock, buy or sell ATEC, CarpeDiem, contrarian investing, ContrarianInvestment, featured-insiders, free cash flow, FUNanc1al, FunStock Index, growth stocks, hub-insiders, insider buying, insider purchases, InsiderBuying, Keith Valentine, medical technology, MedTech, medtech stocks, OsteoAdapt, Pat Miles, PatMiles, Patrick Miles, risks buying ATEC, RoboticSurgery, short interest, short squeeze, ShortSqueeze, small cap stocks, spine surgery, SpineSurgery, surgical robotics, turnaround stocks, TurnAroundStock, Valence robotics, ValueInvesting, why buy ATEC

Quick links

Search
About/Leadership
Editorial Process
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service

Contact us

@funanc1al
customer_service@funanc1al.com

About us

FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.

Follow us

Twitter
Instagram
TikTok
Linkedin
Youtube
Tumblr

© Copyright 2026 FUNanc1al
Powered by Shopify